Book Review: Transhumanist Dreams and Dystopian Nightmares
By John Galloway,
BioNews
| 03. 11. 2013
Perhaps fortuitously, I started to read
Maxwell Mehlman's
book at the same time as
Roy Porter's 'A Short History of Madness'. It was then difficult not to muse on what
Jonathan Swift might have made of 'transhumanising scientists'. His satirising of scientists 'infected with lunacy' in the eighteenth century provides a hard to avoid parallel with Mehlman's very much not satirical account of biologists of the twentieth century.
Every school child now knows that molecular genetics is set to transform the world as we know it. Although exactly who 'we' are, is not specified; nor are we always told whether the transformation will be for good or ill. We can be reasonably certain though that most of the world's existing population will be dead before genetics' claims for medicine have any effect on them.
Read more...
Related Articles
By Grace Won, KQED [with CGS' Katie Hasson] | 12.02.2025
In the U.S., it’s illegal to edit genes in human embryos with the intention of creating a genetically engineered baby. But according to the Wall Street Journal, Bay Area startups are focused on just that. It wouldn’t be the first...
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
Alice Wong, founder of the Disability Visibility Project, MacArthur Genius, liberationist, storyteller, writer, and friend of CGS, died on November 14. Alice shone a bright light on pervasive ableism in our society. She articulated how people with disabilities are limited not by an inability to do things but by systemic segregation and discrimination, the de-prioritization of accessibility, and the devaluation of their lives.
We at CGS learned so much from Alice about disability justice, which goes beyond rights...
By Adam Feuerstein, Stat | 11.20.2025
The Food and Drug Administration was more than likely correct to reject Biohaven Pharmaceuticals’ treatment for spinocerebellar ataxia, a rare and debilitating neurodegenerative disease. At the very least, the decision announced Tuesday night was not a surprise to anyone paying attention. Approval...